Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update
Go back to Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update| (NYSE: RCUS) | Delayed: 29.66 -0.47 (1.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.13 | 52 Week High | $ | |||
| Open | $29.64 | 52 Week Low | $ | |||
| Day High | $30.10 | P/E | N/A | |||
| Day Low | $29.40 | EPS | $ | |||
| Volume | 736,983 | |||||

